Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Cutera Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that on October 3, 2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Brent Hauser, who joined Cutera on October 2, 2023, as the President, International. The inducement awards consisted of restricted stock units (RSUs) settleable in 27,358 shares of common stock, and two grants of performance stock units (PSUs) settleable in 54,716 shares of common stock and 25,000 shares of common stock, respectively.

The RSUs were granted on October 3, 2023. A quantity of 25% shall vest on October 2, 2024, and 1/12 of the RSUs shall vest each quarter thereafter, subject to Mr. Hauser continuing as an employee.

The PSU grants were granted on October 3, 2023. Regarding the PSU grant of 54,716 shares of common stock, the performance-based vesting schedule and targets will be determined by Cutera’s Board of Directors or Compensation Committee. The PSU grant of 25,000 shares of common stock has a single performance criteria of the 30-calendar day trailing average of Cutera’s closing common stock price exceeding $20.00 within four years of the grant date.

Each inducement award is subject to the terms of the Cutera, Inc. 2023 Inducement Equity Incentive Plan and related forms of agreements and were granted as inducements material to these employees to enter into employment with Cutera in accordance with Nasdaq Listing Rule 5635(c)(4).

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Contacts

Greg Barker

VP, Corporate FP&A and Investor Relations

415-657-5500

IR@cutera.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.